title: (-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus.
abstract: Alzheimer's disease (AD) fundamentally represents a metabolic disease associated with brain insulin resistance. TNF-α/c-Jun N-terminal kinase (JNK) signaling plays a central role in serine phosphorylation of insulin receptor substrate-1 (IRS-1). (-)-Epigallocatechin-3-gallate (EGCG), a potent antioxidant, has been verified to attenuate peripheral insulin resistance by reducing IRS-1 signaling blockage. This study aimed to investigate the effects and possible mechanisms of EGCG on central IRS-1 signaling in vivo. APP/PS1 mice were treated with EGCG, and spatial memory was assessed by the Morris water maze test. Levels of soluble and insoluble Aβ42 in the hippocampus were determined by ELISA. The activation of NF-α/JNK and IRS signaling was detected by immunohistochemistry and Western blot analysis. Our results showed that EGCG ameliorated the impaired learning and memory in APP/PS1 mice. Notably, we found a significant reduction of IRS-1pS636 level accompanied with decreased Aβ42 levels in the hippocampus of 13-month-old female APP/PS1 mice after treatment with EGCG (2 or 6 mg/kg/day) for 4 weeks. Furthermore, EGCG treatment inhibited TNF-α/JNK signaling and increased the phosphorylation of Akt and glycogen synthase kinase-3β in the hippocampus of APP/PS1 mice. In conclusion, our study provides evidence that long-term consumption of EGCG may alleviate AD-related cognitive deficits by effectively attenuating central insulin resistance.
authors: Department of Neurology, First Affiliated Hospital of China Medical University, No. 155 Nanjing North Street, Heping District, Shenyang 110001, Liaoning Province, China.
authors: Ning
authors: N
authors: Jia
authors: Kun
authors: K
authors: Han
authors: Jing-Jing
authors: JJ
authors: Kong
authors: Xiu-Mei
authors: XM
authors: Zhang
authors: Sha
authors: S
authors: Sha
authors: Gui-Ru
authors: GR
authors: Ren
authors: Yun-Peng
authors: YP
authors: Cao
mesh_terms: D000544:Alzheimer Disease / Q000235:genetics / Q000378:metabolism / Q000517:prevention & control; D016229:Amyloid beta-Peptides / Q000378:metabolism; D016564:Amyloid beta-Protein Precursor / Q000235:genetics / Q000378:metabolism; D000818:Animals; D015153:Blotting, Western; D002392:Catechin / Q000031:analogs & derivatives* / Q000494:pharmacology; D004195:Disease Models, Animal; D005260:Female; D038362:Glycogen Synthase Kinase 3 / Q000378:metabolism; D000071679:Glycogen Synthase Kinase 3 beta; D006624:Hippocampus / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D007150:Immunohistochemistry; D055504:Insulin Receptor Substrate Proteins / Q000378:metabolism*; D048031:JNK Mitogen-Activated Protein Kinases / Q000378:metabolism; D018782:Maze Learning / Q000187:drug effects; D008569:Memory Disorders / Q000503:physiopathology / Q000517:prevention & control*; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D010446:Peptide Fragments / Q000378:metabolism; D010766:Phosphorylation / Q000187:drug effects; D053764:Presenilin-1 / Q000235:genetics / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D012694:Serine / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; D055504:Insulin Receptor Substrate Proteins; C508853:PSEN1 protein, human; D010446:Peptide Fragments; D053764:Presenilin-1; D014409:Tumor Necrosis Factor-alpha; C075222:amyloid beta-protein (1-42); D012694:Serine; D002392:Catechin; C045651:epigallocatechin gallate; C000605506:GSK3B protein, human; D000071679:Glycogen Synthase Kinase 3 beta; C000605507:Gsk3b protein, mouse; D051057:Proto-Oncogene Proteins c-akt; D048031:JNK Mitogen-Activated Protein Kinases; D038362:Glycogen Synthase Kinase 3
references: Neuron. 2008 Jun 12;58(5):708-19
references: 18549783
references: Nat Rev Mol Cell Biol. 2007 Feb;8(2):101-12
references: 17245412
references: J Agric Food Chem. 2012 Feb 1;60(4):1059-66
references: 22191431
references: Trends Endocrinol Metab. 2012 Mar;23(3):133-41
references: 22245457
references: Biochimie. 2005 Jan;87(1):99-109
references: 15733744
references: J Neurol Sci. 2012 Apr 15;315(1-2):39-43
references: 22265943
references: Brain Res. 2008 Jun 12;1214:177-87
references: 18457818
references: Mol Cell Biochem. 2011 May;351(1-2):197-205
references: 21249428
references: Mol Cell Biochem. 2011 Aug;354(1-2):1-10
references: 21633901
references: J Neurol Sci. 2007 Jun 15;257(1-2):250-4
references: 17362999
references: J Neurosci. 2005 Sep 21;25(38):8807-14
references: 16177050
references: Diabetes Res Clin Pract. 2011 Aug;93(2):205-214
references: 21514684
references: Mol Cell Biochem. 2012 Jan;359(1-2):161-7
references: 21850461
references: Curr Alzheimer Res. 2012 Jan;9(1):35-66
references: 22329651
references: J Clin Invest. 2012 Apr;122(4):1339-53
references: 22476196
references: Mol Cell Biochem. 2013 Jan;372(1-2):83-94
references: 22971992
references: J Nutr. 2009 Oct;139(10):1987-93
references: 19656855
references: J Clin Invest. 2012 Apr;122(4):1316-38
references: 22476197
references: Planta Med. 2004 Nov;70(11):1100-2
references: 15549673
references: Nature. 2002 Nov 21;420(6913):333-6
references: 12447443